Monarch Medical Technologies., a Charlotte-based provider of electronic systems for inpatient glycemic management, has named its new CEO and president.

The company announced that Bruce Lisanti would step in as its CEO and president. Lisanti would succeed Linda Beneze who retired from her role as Monarch CEO.

Michel’s appointment to those positions would take effect immediately.

“I’m very excited to be joining Monarch at this moment in the healthcare industry and work with this phenomenal team to advance inpatient diabetes care,” Lisanti said in a statement. “As more hospitals face financial pressures under value-based care payment models and increased competition with the rise of healthcare consumerism, the need to improve inpatient diabetes care is no longer just what is in the best interest of the patient, but also the provider’s bottom-line.”

Lisanti is an experienced senior level executive in health care, technology and services industries.

As a leader in precision insulin dosing technology for optimized glycemic management, Monarch offers an EndoTool Glucose Management System which helps to provide personalized dosing recommendations for intravenous and subcutaneous insulin therapy.

As a Class II FDA-cleared, patented software suite, EndoTool has enabled more than 260 hospitals to provide unsurpassed patient-specific glycemic control across a broad population of patients.